BioNexus Gene Lab Corp (BGLC): Total Liabilities
$637.9K
As of 2025-12-31
$948.0K
As of 2026-06-30
-32.5%
3-year compound annual growth
-28.7%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $637.9K | -69.8% | 2026-04-14, Balance as of period end |
| 2024-12-31 | $2.11M | +21.2% | 2026-04-14, Balance as of period end |
| 2023-12-31 | $1.74M | -16.1% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $2.08M | -13.3% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $2.39M | -30.7% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $3.45M | n/m | 2022-04-06, Balance as of period end |
| 2019-12-31 | $108.9K | -16.5% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $130.3K | n/a | 2020-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $637.9K | -69.8% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $72.98M | +8.4% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
| YD Bio Ltd (YDES) | 2025-12-31 | $16.64M | n/m |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $344.15M | -28.3% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $152.55M | +13.6% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
Compare BGLC, AMS, XGN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗